Misonix (MSON) Misses Q3 EPS by 1c

Go back to Misonix (MSON) Misses Q3 EPS by 1c

Misonix, Inc. Announces Third Quarter Fiscal Year 2015 Financial Results

May 7, 2015 4:01 PM EDT

FARMINGDALE, N.Y., May 7, 2015 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today announced financial results for the third quarter of fiscal 2015, ended March 31, 2015.

Highlights for the third quarter fiscal 2015 included:

Net sales totaled $5.3 million, a 24% increase, compared to $4.3 million for the same period in fiscal 2014. BoneScalpel revenue worldwide increased 27% to $2.2 million versus $1.7 million in the... More